Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

BIO Welcomes 2013 Renewable Fuel Standard Rules

Published: Monday, February 04, 2013
Last Updated: Monday, February 04, 2013
Bookmark and Share
The Renewable Fuel Standard continues to ensure that the U.S. fuel market will be open to advanced and cellulosic biofuels as producers ramp up production.

The Biotechnology Industry Organization (BIO) today welcomed the Environmental Protection Agency’s release of proposed RFS rules and volume projections for 2013:

“This is a pivotal year for cellulosic and advanced biofuels. Following years of research and development and millions of dollars in investment, companies are right now commissioning commercial cellulosic biofuel refineries and constructing additional facilities – creating thousands of new jobs in the process. The visible progress of the industry is proof that the Renewable Fuel Standard works.

“BIO will work with EPA to finalize these rules in an expeditious manner so that advanced and cellulosic biofuel producers can continue working to meet the energy security and environmental health goals of the nation. By contrast, we fully expect the trade organizations for oil companies and their allies to continue to use every regulatory and legalistic ploy at their disposal to delay finalization of these rules, block the growth of the renewable fuel industry and attempt to preserve their control of the fuel market.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BIO to Use ViS Analytics to Streamline Pediatric Clinical Research
Pediatric research is essential to study the effects of new therapeutics in children.
Thursday, May 09, 2013
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Epigenetics and Neural Cell Death
Researchers demonstrate how deregulation of an epigenetic mechanism active in early neurogenesis phases triggers neural cell death.
Ebola-Affected Countries Receive NIH Support
The National Institutes of Health has established a new program to further research capacity to study Ebola and other epidemics.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Skin Patch to Treat Peanut Allergy
NIH-funded study suggests peanut protein patch is a safe and convenient method of treatment.
Molecular Origins of Dust Mite Allergy Discovered
Scientists have identified molecules of house dust mites that are targeted by the immune system of children, developing allergic rhinitis and asthma.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos